Zhang Xiaobo, Gao Xidan, Xu Jing, Zhang Zhuoya, Lin Tingtong, Zhang Xueyan, Kang Xin
Department of Spine Surgery, Honghui Hospital, Xi'an Jiao Tong University, 710054 Xi'an, Shaanxi Province, China.
The Second Clinical Medical College of Lanzhou University, 730000 Lanzhou, Gansu, China.
Int Immunopharmacol. 2025 Jan 10;144:113726. doi: 10.1016/j.intimp.2024.113726. Epub 2024 Nov 29.
Osteosarcoma is a common primary malignant bone tumor with a high incidence in children and adolescents, with high invasiveness and lung metastases. Even after traditional surgical excision, chemoradiotherapy, and comprehensive treatment, the survival rate of patients is still low, and the prognosis is not ideal. As an important part of non-coding RNA family, lncRNA and miRNA have significant regulatory effects on the growth, proliferation, metastasis and apoptosis of osteosarcoma cells. Therefore, exploring the roles of lncRNAs and miRNAs in the occurrence and development of osteosarcoma is of great help for the subsequent diagnosis, treatment, and prognosis of osteosarcoma. This paper mainly reviews the current research progress on the effects and mechanisms of lncRNAs and miRNAs on osteosarcoma cells, in order to provide new ideas for future research on the development process, treatment methods, and prognosis of osteosarcoma.
骨肉瘤是一种常见的原发性恶性骨肿瘤,在儿童和青少年中发病率较高,具有高侵袭性和肺转移特性。即使经过传统的手术切除、放化疗及综合治疗,患者的生存率仍然较低,预后并不理想。作为非编码RNA家族的重要组成部分,长链非编码RNA(lncRNA)和微小RNA(miRNA)对骨肉瘤细胞的生长、增殖、转移及凋亡具有显著的调控作用。因此,探究lncRNA和miRNA在骨肉瘤发生发展中的作用,对骨肉瘤后续的诊断、治疗及预后具有极大帮助。本文主要综述lncRNA和miRNA对骨肉瘤细胞作用及机制的当前研究进展,以期为未来骨肉瘤发生发展过程、治疗方法及预后的研究提供新思路。